$LEXX 1. BioDelivery Sciences ($BDSI)
BioDelivery Sciences followed a nearly identical trajectory by using its BEMA® (BioErodible MucoAdhesive) delivery technology.
• The Path: The company spent years developing and evaluating its delivery platform for various pain and addiction medications.
• The Deal: In 2012, they converted their development progress into a worldwide licensing agreement with Endo Pharmaceuticals for BEMA Buprenorphine.
• Terms: The deal included a $30 million upfront payment and up to $150 million in milestone payments, plus royalties on net sales. BDSI was later acquired for over $560 million in 2022.
@FatMoneyScience @mikedeatworld If Steve ever does show for that beer for the love of God please tell him to contact $BDSI so they can partner up on a buccal (cheek) patch for delivery of bremelanotide (since it works intranasally it should work via the cheek too and it's a lot sexier sticking your finger in your cheek than up your nose).
$BDSI BioDelivery Sciences International, Inc. (NASDAQ:BDSI): A Diversified Specialty Pharmaceutical Company Delivering Innovative Therapies https://beyondspx.com/article/biodelivery-sciences-international-inc-nasdaq-bdsi-a-diversified-specialty-pharmaceutical-company-delivering-innovative-therapies
$BDSI BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company that focuses on delivering innovative therapies for individuals living with serious and debilitating chronic conditions. The company has two main product segments – BELBUCA and Symproic. https://beyondspx.com/article/biodelivery-sciences-international-inc-nasdaq-bdsi-a-diversified-specialty-pharmaceutical-company-delivering-innovative-therapies
$BDSI BioDelivery Sciences International, Inc. (NASDAQ:BDSI): A Diversified Specialty Pharmaceutical Company Delivering Innovative Therapies http://beyondspx.com/2024/08/05/biodelivery-sciences-international-inc-nasdaqbdsi-a-diversified-specialty-pharmaceutical-company-delivering-innovative-therapies/
@Muhley I agree there is some hope of optimism behind the 8-K announcement although I'm not sure how much incentive management really has to dilute *after* prices spike instead of before, but we can hope and + I recall you are going on previous conversation with $PTN mgmt regarding their plans and I mentioned they have good things coming end of this month in the conference. I've never had luck contacting them so I hope if you ever converse again you bring up the $BDSI buccal patch since they easily may want to partner without requiring money out of PTN pockets other than just supplying some brem to formulate into a few trial cheek patches to verify it gets in the bloodstream in controlled fashion. No need to verify efficacy or safety. Low investment big reward.
$BDSI Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC
https://newsfilter.io/a/14d1cf121593b93926057d6634026a3b
@Gerszon Agreed future is bright. Patience needed. Melanocortins very promising. It's frustrating being a long time shareholder when at todays prices my first purchased shares would cost roughly $800 ea now. So I would rather see ED back in the news now for Bremelanotide while still in PTNs court so that share price can recover a bit. Men are more aggressive buyers (if they only knew) would start going recreational in the meantime with off-label borrowing from their female partners of their Vyleesi prescription and bump sales numbers further. As for a patch I'm the only one I know that has suggested a buccal patch, see $BDSI product. Cheek a lot "sexier" route than sticking your finger up your nose.
@Paperchasin it would be a slam dunk for $PTN to do a patch either for the nose or cheek and also revisit erectile dysfunction. $BDSI has a cheek patch that they use to deliver a fentanyl type opioid that is not absorbable in the stomach and requires strict dosage regulation .. that doesn't mean it'll work for vyleesi but it might and a cheek patch is sexier than sticking your finger up your nose.
$BDSI Can you imagine the people who who didn't offload this in 2019? Almost as crazy as a doctorate who believes both political parties are equally extreme and flawed.
$NMTRQ Some of the NMTR insiders also have shares in $BDSI. BDSI was recently bought out by Collegium pharmaceuticals. I wonder if there are any connections there.
